Archive for April, 2009
Welcome! This Web site combines prostate cancer news, expert commentary, relevant clinical findings, updates on important prostate cancer research, and personal case histories to help you fully understand the important considerations in the diagnosis and treatment of disorders of the prostate. We hope you find it useful.
Given the possible side effects of hormone therapy, such as bone loss, fractures, diabetes, and heart trouble, clinicians might want to think twice before prescribing hormone therapy as the primary cancer treatment for older men with early-stage disease.
No consensus exists about what type of medical follow-up is in order for this “precancerous” condition or whether to treat it. Marc B. Garnick, M.D., explains the condition and outlines your options.
Study shows that patients have fewer complications when prostate surgery is done at a high-volume hospital by a surgeon who performs the operation regularly.
An experimental drug may halt the production of male hormones in the body, making it a promising treatment for prostate cancer patients whose tumors have not responded to other therapies. Preliminary studies showed shrinking tumors and drops in PSA levels.
Study shows that men with BPH typically eat less garlic and fewer servings of onions per week than those without BPH.
Many urologists prescribe alpha blockers to treat chronic prostatitis, but study shows that one such drug is ineffective in easing the condition.
A new prostate cancer vaccine may give hope to men with metastatic prostate cancer by spurring their immune systems to fight the disease, according to a presentation by Iowa researchers at the American Urological Association’s annual meeting in May 2008. Enabling a patient’s immune system to attack cancer cells can improve quality of life and extend survival.
Despite previous controversy, researchers report that finasteride may reduce overall disease risk and decrease rate of aggressive tumors.